Lydia Bellmann

4PUBLICATIONS
25CO-AUTHORS
Innate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 21, 2021
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.

Lydia Bellmann, Helen Strandt, Claudia Zelle-Rieser

|Jan 07, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.

Anastasia Prokopi, Christoph H Tripp, Bart Tummers

|Sep 24, 2020
CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice.

Dominik Eichin, Alberto Pessia, Akira Takeda

|Nov 09, 2019
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma model.

Lydia Bellmann, Giuseppe Cappellano, Johanna F Schachtl-Riess

Pageof 1